Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00963989 · ClinicalTrials.gov registry record · NA
Imaging Guided Patient Selection for Interventional Revascularization Therapy
A NA study of Acute Ischemic Stroke, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT00963989 is a NA study of Acute Ischemic Stroke that has completed, run by Penumbra. The registered enrollment target is 146 participants, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00963989, a NA study of Acute Ischemic Stroke, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation between infarct volume and functional outcome in treated patients at 90 days post-procedure.
Conditions Studied
Interventions
- DEVICE Penumbra System
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00963989
The ClinicalTrials.gov registry entry for NCT00963989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (58% lower). The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Penumbra System is the first listed.
NCT00963989 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00963989 about?
NCT00963989 is a clinical study titled "Imaging Guided Patient Selection for Interventional Revascularization Therapy". The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation betwe...
What is the current status of trial NCT00963989?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2009-09. Estimated completion is 2016-09.
What conditions does trial NCT00963989 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT00963989?
The interventions under investigation include: Penumbra System (DEVICE).
Who is sponsoring clinical trial NCT00963989?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00963989 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
-
The Pivotal Study of RapidPulseTM Aspiration System
RECRUITING · NA
-
An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke
ACTIVE NOT RECRUITING · NA
-
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
ACTIVE NOT RECRUITING · NA
-
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.